Fabino Life Sciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	2.7yrs

Recent management updates

Recent updates

CEO

Fabino Life Sciences has no CEO, or we have no data on them.

Board Members

Name	Position	Tenure	Compensation	Ownership
Atul Jain	Chairman	12.7yrs	no data	56.82% ₹ 31.1m
Aditya Jain	MD & Director	2.7yrs	no data	no data
Arihant Jain	Non-Executive Director	3.5yrs	no data	no data
Kuldeep Solanki	Non-Executive Independent Director	2.6yrs	no data	no data
Tesu Alakh	Non-Executive Independent Director	2.7yrs	no data	no data
Gagan Gupta	Non-Executive Independent Director	2.7yrs	no data	no data
Sumit Malik	Non-Executive Non-Independent Director	2.1yrs	no data	1% ₹ 547.1k

2.7yrs

Average Tenure

37yo

Average Age

Experienced Board: 543444's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Fabino Life Sciences Management

Management criteria checks 0/4

Key information

Recent management updates

High number of new directors

High number of new directors

High number of new directors

Fabino Life Sciences Limited Approves Executive Changes

Fabino Life Sciences Limited Approves Executive Changes

High number of new directors

Recent updates

Full year 2024 earnings released: EPS: ₹0.17 (vs ₹0.051 in FY 2023)

Fabino Life Sciences Limited to Report Q2, 2024 Results on May 28, 2024

Investor sentiment improves as stock rises 16%

High number of new directors

Investor sentiment deteriorates as stock falls 19%

High number of new directors

High number of new directors

Fabino Life Sciences Limited Approves Executive Changes

Fabino Life Sciences Limited Approves Executive Changes

High number of new directors

Fabino Life Sciences Limited to Report Q2, 2024 Results on Nov 10, 2023

High number of new and inexperienced directors

Fabino Life Sciences Limited, Annual General Meeting, Sep 12, 2023

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: ₹0.05 (vs ₹0.22 in FY 2022)

High number of new and inexperienced directors

Fabino Life Sciences Limited to Report Second Half, 2023 Results on May 24, 2023

High number of new and inexperienced directors

Investor sentiment improves as stock rises 17%

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Fabino Life Sciences Limited to Report Q2, 2022 Results on Nov 09, 2022

High number of new and inexperienced directors

Fabino Life Sciences Limited, Annual General Meeting, Sep 22, 2022

Fabino Life Sciences Limited Appoints Aslam Mohamrnad as Company Secretary and Compliance Officer

Fabino Life Sciences Limited Announces Resignation of Jeel Poshiya as Company Secretary and Compliance Officer, Effective August 04, 2022

Less than half of directors are independent

Full year 2022 earnings released: EPS: ₹0.22 (vs ₹0.50 in FY 2021)

Fabino Life Sciences Limited Appoints Sumit Malik as Additional Director (Non-Executive)

Fabino Life Sciences Limited Appoints Sumit Malik as Additional Director (Non-Executive)

Fabino Life Sciences Limited to Report First Half, 2022 Results on May 24, 2022

High number of new and inexperienced directors

High number of new and inexperienced directors

CEO

Board Members

Average Tenure

Average Age